{'fraction_non_alphanumeric': 0.04908675799086758, 'fraction_numerical': 0.01598173515981735, 'mean_word_length': 5.401459854014599, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
In vitro biosynthesis of pseudouridine at the polynucleotide level by an enzyme extract from Escherichia coli.

DNA from Mycoplasma sp. Kid which was enriched for tRNA genes (containing about 10% tDNA) was transcribed by E. coli RNA polymerase. The RNA transcription product labeled with [(14)C]uridine was formed in good yield (70-fold net synthesis). After incubation of this [(14)C]uridine-labeled RNA with E. coli extracts, nucleotide analyses revealed that [(14)C]pseudouridine was formed. The experiments support the idea that the conversion of uridine to pseudouridine takes place at the macromolecular level. Furthermore, the conversion was shown to be specific for a uridine residue in tRNA-like material since neither [(14)C]polyuridylic acid nor the [(14)C]uridine-labeled RNA transcribed from lambda DNA served as substrate for the pseudouridine-forming enzyme(s).